Overview of Electroencephalographic Monitoring in the ICU
This event has passed and can no longer be viewed
This event was presented live or live-streamed and has not been designated for on-demand presentation.
This Pediatric Neurocritical Care Lecture Series session will take place on Friday, February 10, 2023 at 1:00 p.m. Attendance will only be available virtually through Zoom. Register at http://bit.ly/PNCCES_2-10-2023. You will receive a link to access the presentation after you have registered. In advance of the session, create your CME account and profile at cpd.education.bcm.edu.
Contact Information (please send clinical questions/cases): PNCC.Lectures@gmail.com. Follow PNCC on Vimeo at: https://vimeo.com/channels/pncc (recordings not designated for CME).
Activity Information
Needs Statement
Pediatric critical care physicians, pediatric neurologists, advanced practice providers, fellows, and residents need to receive regular updates on pediatric critical care research and advances in the care of critically ill children with neurological conditions. Interpretation of pathological findings derived from advanced neuro-monitoring modalities will be emphasized as a means to guide treatment and detect harmful physiological events early. The aim of the series is to expand clinical knowledge, promote adherence to evidence-based guidelines, enhance the quality of pediatric neurocritical care, disseminate best clinical practices, reduce variations in clinical practice, and improve patient outcomes.
Educational Objectives
At the conclusion of the session, the participants should be able to:
- Discuss four injuries or conditions that place a patient at risk for seizures.
- Identify one favorable and one unfavorable electroencephalographic feature associated with prognosis
following cardiac arrest. - Describe how the electroencephalographic power spectrogram changes with cerebral blood flow.
Target Audience
Professional Categories
- Physicians
- Fellows
- Residents
- Other Health Professionals
Specialties
Interest Groups
- Hospital Medicine
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Director
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Rejean Guerriero, D.O.
Associate Professor of Neurology; Vice Chair, Division of Pediatric Neurology
Washington University School of Medicine in St. Louis
Disclosure:
Nothing to disclose.
Activity Director
Planning Committee Members
-
Jennifer Erklauer, M.D.
Assistant Professor
Baylor College of Medicine, Texas Children's Hospital
Disclosure:
Nothing to disclose.
-
Sue Hong-Routson, M.D.
Assistant Professor
Ann & Robert H. Lurie Children's Hospital of Chicago
Disclosure:
Nothing to disclose.
-
-
Dennis Simon, M.D.
Assistant Professor
Children's Hospital of Pittsburgh
Disclosure:
Nothing to disclose.
-
Ajay Thomas, M.D., Ph.D.
Pediatric Neurology Fellow
Baylor College of Medicine, Texas Children's Hospital
Disclosure:
Nothing to disclose.
Health Topics
Presenter: